DSM, a biomedical materials developer, has entered into a license and supply agreement with SpineVision, an implant manufacturer.
SpineVision may use DSM's proprietary polymer, Bionate II PCU, in its Flex+2 system, as per the agreement. The Flex+2 system is designed for early disc degeneration treatment, as well as total disc degeneration and fusion procedures. DSM's polymer wraps around the metal wire and provides stabilization and extension, according to the release.
The Flex+2 device with Bionate II PCU material will soon launch in the European Union. It is not yet available in the U.S.
More Articles on Devices:
Stryker Launches Spinal Pedicle Screw
500 Invibio PEEK-OPTIMA Devices Cleared for US Use
VertiFlex to Sell Spine Technology to Stryker
The Flex+2 device with Bionate II PCU material will soon launch in the European Union. It is not yet available in the U.S.
More Articles on Devices:
Stryker Launches Spinal Pedicle Screw
500 Invibio PEEK-OPTIMA Devices Cleared for US Use
VertiFlex to Sell Spine Technology to Stryker
